You are here:

Home
NICE Guidance
Conditions and diseases
Infections
Influenza

Oseltamivir, amantadine (review) and zanamivir for the prophylaxis of influenza

Technology appraisal guidance
Reference number: TA158
Published: 24 September 2008

Guidance
Tools and resources
Information for the public
History

Consultee and commentator comments on the ACD

Manufacturer/sponsor: GlaxoSmithKline
Manufacturer/sponsor: Roche
Professional and patient groups: British Thoracic Society
Professional and patient groups: Diabetes UK
Professional and patient groups: General Practice Airways Group
Professional and patient groups: Health Protection Agency
Professional and patient groups: Royal College of Paediatrics and Child Health
Professional and patient groups: Royal College of Physicians
Professional and patient groups: Royal College of Nursing
Others: Department of Health
Others: NHS Quality Improvement Scotland
Others: Welsh Assembly Government

This page was last updated: 30 March 2010